{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:44:09Z","timestamp":1773369849724,"version":"3.50.1"},"reference-count":8,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,26]]},"DOI":"10.1182\/blood.2024025497","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T15:41:36Z","timestamp":1727365296000},"page":"1351-1352","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Pirtobrutinib combinations in CLL"],"prefix":"10.1182","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5611-6115","authenticated-orcid":false,"given":"Jeff P.","family":"Sharman","sequence":"first","affiliation":[{"name":"Willamette Valley Cancer Center"},{"name":"Sarah Cannon Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"13","key":"2024092615302243700_bib1","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood.2024024510","article-title":"Fixed-duration pirtobrutinib plus venetoclax with or without rituximab in relapsed\/refractory CLL: the phase 1b BRUIN trial","volume":"144","author":"Roeker","year":"2024","journal-title":"Blood"},{"key":"2024092615302243700_bib2","author":"Ehrlich","year":"1909"},{"key":"2024092615302243700_bib3","author":"DeVita","year":"2015"},{"issue":"2","key":"2024092615302243700_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1182\/blood-2015-06-651125","article-title":"Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial","volume":"127","author":"Fischer","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2024092615302243700_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13045-023-01469-7","article-title":"Unresolved questions in selection of therapies for treatment-na\u00efve chronic lymphocytic leukemia","volume":"16","author":"Bennett","year":"2023","journal-title":"J\u00a0Hematol Oncol"},{"issue":"12","key":"2024092615302243700_bib6","first-page":"1423","article-title":"Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial","volume":"24","author":"Niemann","year":"2023","journal-title":"Lancet\u00a0Oncol"},{"issue":"3","key":"2024092615302243700_bib7","first-page":"835","article-title":"Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies","volume":"109","author":"Woolston","year":"2024","journal-title":"Haematologica"},{"issue":"3","key":"2024092615302243700_bib8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1158\/1078-0432.CCR-22-3934","article-title":"Absence of BTK, BCL2, and PLCG2 mutations in chronic lymphocytic leukemia relapsing after first-line treatment with fixed-duration ibrutinib plus venetoclax","volume":"30","author":"Jain","year":"2024","journal-title":"Clin Cancer Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/13\/1351\/2244087\/blood_bld-2024-025497-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/13\/1351\/2244087\/blood_bld-2024-025497-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T19:24:27Z","timestamp":1732821867000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/144\/13\/1351\/517894\/Pirtobrutinib-combinations-in-CLL"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":8,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,9,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024025497","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,26]]}}}